Current studies focusing on these novel peptides, a distinct category of molecules showing significant potential for modulating multiple condition pathways. Compared to existing small molecule methods, Nexaph chains provide improved targeting and lesser off-target reactions, making them a particularly encouraging option for potential therapeutic cr